FCPM III Services B.V.
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 14, 2026), FCPM III Services B.V. reported 11 stock positions worth $750.4 million. Its top holding was Newamsterdam Pharma (NAMS) at 38.3% of the portfolio, followed by Maplight Therapeutics (MPLT, 15.4%) and Dyne Therapeutics (DYN, 11.4%). Compared with Q1 2026, it opened 1 new position and reduced 2. The biggest buy was a new position in Aura Biosciences (AURA) and the biggest sale Newamsterdam Pharma (NAMS, shares −8%).
- Most Recent 13F
- Q2 2026
- Location
- NAARDEN, P7
- CIK
- 0002013410
- Portfolio Value
- $750.4M (Q2 2026)
- SEC Filing
- 0001193125-26-350207 ↗ filed Aug 14, 2026
Holdings Value
Holdings 11 stocks · $750.4M
| NAMS Newamsterdam Pharma Co. NV | 38.34% | 8,490,353 | $287.7M | Reduce -7.7% |
| MPLT Maplight Therapeutics Inc. | 15.41% | 3,226,400 | $115.6M | No change |
| DYN Dyne Therapeutics Inc. | 11.39% | 3,848,256 | $85.5M | Reduce -17.1% |
| VOR Vor Biopharma Inc. | 10.10% | 4,117,354 | $75.8M | No change |
| DMRA Damora Therapeutics Inc. | 8.46% | 2,441,000 | $63.5M | No change |
| REPL Replimune Group Inc. | 4.14% | 2,808,368 | $31.1M | No change |
| CBIO Crescent Biopharma Inc. | 4.02% | 1,677,852 | $30.2M | No change |
| AURA Aura Biosciences Inc. | 3.84% | 4,053,775 | $28.8M | New |
| ENGN Engene Holdings Inc. | 2.22% | 9,632,561 | $16.7M | No change |
| BCYC Bicycle Therapeutics PLC-ADR | 1.96% | 3,468,430 | $14.7M | No change |
| ENGENE HOLDINGS INC | 0.11% | 2,878,148 | $834K | No change |
Portfolio Sells Q1 2026 → Q2 2026
Portfolio Buys Q1 2026 → Q2 2026
| AURA Aura Biosciences Inc. | New | 3.84% | +3.84 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 11 | $750.4M | NAMS, MPLT, DYN, VOR, DMRA |
| Q1 2026 | 10 | $722.2M | NAMS, DYN, VOR, ENGN, MPLT |
| Q4 2025 | 10 | $762.9M | NAMS, DYN, ENGN, RAPT, MPLT |
| Q3 2025 | 9 | $500.4M | NAMS, DYN, ENGN, ATXS, BCYC |
| Q2 2025 | 8 | $369.2M | NAMS, DYN, REPL, ENGN, BCYC |
| Q1 2025 | 7 | $413.7M | NAMS, DYN, ENGN, REPL, BCYC |
| Q4 2024 | 8 | $592.4M | NAMS, DYN, ENGN, BCYC, REPL |
| Q3 2024 | 7 | $582.3M | DYN, NAMS, ENGN, REPL, BCYC |
| Q2 2024 | 7 | $678.1M | DYN, NAMS, ENGN, REPL, BCYC |
| Q1 2024 | 6 | $707.3M | NAMS, DYN, ENGN, REPL, ENGENE HOLDINGS INC |